FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214545089> ?p ?o ?g. }

• W4214545089 endingPage "1192" @default.
• W4214545089 startingPage "1192" @default.
• W4214545089 abstract "Leptomeningeal metastasis is a neurological complication from HER2-positive breast cancer with a poor prognosis and limited treatment options. This study has evaluated the activity of neratinib in association with capecitabine in 10 patients with LM from HER2-positive BC after the failure of multiple lines of treatment, including trastuzumab-based therapy, within a compassionate program, and a comparison was made with a historical control group of 10 patients.Patients aged ≥ 18 years with histological diagnosis of primary HER2-positive BC, either amplified or mutated, and newly-diagnosed LM were enrolled. Coexistence of BM that has or has not received radiotherapy, as well as prior chemotherapy, hormone therapy, or monoclonal HER2-targeting antibodies or antibody-drug conjugates, were allowed, with the exclusion of lapatinib.Six-months OS was 60% with a median OS of 10 months (95% CI: 2.00-17.0). Three-month intracranial PFS was 60% with a median intracranial PFS of 4.0 months (95% CI: 2.00-6.0). The neurological benefit was observed in 70% of patients with a median duration of neurological response of 6.5 months. The best radiological response was stable disease in 60% of patients.This small series shows that the combination of neratinib and capecitabine is a safe treatment in LM from heavily pretreated HER2-positive BC with clinical efficacy in some patients and is worth investigating in a larger study." @default.
• W4214545089 created "2022-03-02" @default.
• W4214545089 creator A5004271759 @default.
• W4214545089 creator A5023630037 @default.
• W4214545089 creator A5033012865 @default.
• W4214545089 creator A5039031018 @default.
• W4214545089 creator A5049194857 @default.
• W4214545089 creator A5082016746 @default.
• W4214545089 creator A5089715484 @default.
• W4214545089 creator A5090731176 @default.
• W4214545089 date "2022-02-25" @default.
• W4214545089 modified "2023-10-14" @default.
• W4214545089 title "Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program" @default.
• W4214545089 cites W1871221741 @default.
• W4214545089 cites W1937707643 @default.
• W4214545089 cites W1976446970 @default.
• W4214545089 cites W2114195503 @default.
• W4214545089 cites W2136558504 @default.
• W4214545089 cites W2159427817 @default.
• W4214545089 cites W2162618795 @default.
• W4214545089 cites W2174658047 @default.
• W4214545089 cites W2337489755 @default.
• W4214545089 cites W2338611117 @default.
• W4214545089 cites W2734482945 @default.
• W4214545089 cites W2768584883 @default.
• W4214545089 cites W2796338303 @default.
• W4214545089 cites W2887448630 @default.
• W4214545089 cites W2897422388 @default.
• W4214545089 cites W2898137255 @default.
• W4214545089 cites W2901339782 @default.
• W4214545089 cites W2915431268 @default.
• W4214545089 cites W2921212019 @default.
• W4214545089 cites W2921590809 @default.
• W4214545089 cites W2944430908 @default.
• W4214545089 cites W2969448688 @default.
• W4214545089 cites W2995808512 @default.
• W4214545089 cites W3030461309 @default.
• W4214545089 cites W3031665354 @default.
• W4214545089 cites W3033443230 @default.
• W4214545089 cites W3043096450 @default.
• W4214545089 cites W3082806724 @default.
• W4214545089 cites W3104780793 @default.
• W4214545089 cites W3161534002 @default.
• W4214545089 cites W3165169142 @default.
• W4214545089 cites W3165734744 @default.
• W4214545089 cites W3170192455 @default.
• W4214545089 cites W3172623270 @default.
• W4214545089 cites W3174706170 @default.
• W4214545089 cites W3206464970 @default.
• W4214545089 cites W3207557929 @default.
• W4214545089 cites W4243716084 @default.
• W4214545089 cites W605487159 @default.
• W4214545089 doi "https://doi.org/10.3390/cancers14051192" @default.
• W4214545089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35267501" @default.
• W4214545089 hasPublicationYear "2022" @default.
• W4214545089 type Work @default.
• W4214545089 citedByCount "8" @default.
• W4214545089 countsByYear W42145450892022 @default.
• W4214545089 countsByYear W42145450892023 @default.
• W4214545089 crossrefType "journal-article" @default.
• W4214545089 hasAuthorship W4214545089A5004271759 @default.
• W4214545089 hasAuthorship W4214545089A5023630037 @default.
• W4214545089 hasAuthorship W4214545089A5033012865 @default.
• W4214545089 hasAuthorship W4214545089A5039031018 @default.
• W4214545089 hasAuthorship W4214545089A5049194857 @default.
• W4214545089 hasAuthorship W4214545089A5082016746 @default.
• W4214545089 hasAuthorship W4214545089A5089715484 @default.
• W4214545089 hasAuthorship W4214545089A5090731176 @default.
• W4214545089 hasBestOaLocation W42145450891 @default.
• W4214545089 hasConcept C121608353 @default.
• W4214545089 hasConcept C126322002 @default.
• W4214545089 hasConcept C141071460 @default.
• W4214545089 hasConcept C143998085 @default.
• W4214545089 hasConcept C2775930923 @default.
• W4214545089 hasConcept C2777329042 @default.
• W4214545089 hasConcept C2777909004 @default.
• W4214545089 hasConcept C2779413316 @default.
• W4214545089 hasConcept C2779786085 @default.
• W4214545089 hasConcept C509974204 @default.
• W4214545089 hasConcept C526805850 @default.
• W4214545089 hasConcept C530470458 @default.
• W4214545089 hasConcept C71924100 @default.
• W4214545089 hasConceptScore W4214545089C121608353 @default.
• W4214545089 hasConceptScore W4214545089C126322002 @default.
• W4214545089 hasConceptScore W4214545089C141071460 @default.
• W4214545089 hasConceptScore W4214545089C143998085 @default.
• W4214545089 hasConceptScore W4214545089C2775930923 @default.
• W4214545089 hasConceptScore W4214545089C2777329042 @default.
• W4214545089 hasConceptScore W4214545089C2777909004 @default.
• W4214545089 hasConceptScore W4214545089C2779413316 @default.
• W4214545089 hasConceptScore W4214545089C2779786085 @default.
• W4214545089 hasConceptScore W4214545089C509974204 @default.
• W4214545089 hasConceptScore W4214545089C526805850 @default.
• W4214545089 hasConceptScore W4214545089C530470458 @default.
• W4214545089 hasConceptScore W4214545089C71924100 @default.
• W4214545089 hasIssue "5" @default.
• W4214545089 hasLocation W42145450891 @default.
• W4214545089 hasLocation W42145450892 @default.

• next